A newly discovered nuclear role for HSL reveals how imbalances in its location within fat cells may contribute to both ...

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels in diabetic patients and ...

Rare tumors are defined as cancers with an incidence of less than 6 per 100,000 persons per year. Due to their low prevalence ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

Bacterial blight, false smut (Ustilaginoidea virens), and Sheath blight are among the most devastating diseases threatening ...

Learn why research that continues to look for new substrate alternatives is essential to the future of growing.

First year medical student, Mateo Perez, attributes much of his success to programs built for Native youth to connect with Indigenous health practitioner mentors.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...